Roivant Sciences Income Statement (2020-2026) | ROIV

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
684.79M692.01M694.98M701.17M704.39M726.80M760.14M767.14M800.79M804.89M806.68M739.05M733.33M719.63M695.94M682.23M689.70M709.69M720.35M722.67M
Revenue & cost
Revenue (Quarter)
13.99M46.06M4.32M12.53M33.90M21.62M3.65M23.69M7.99M4.47M21.48M2.17M1.57M5.74M1.44M
Gross Profit (Quarter)
7.61M37.56M2.59M8.89M24.95M17.41M3.42M22.29M7.78M4.24M20.78M2.02M1.46M4.78M1.16M
Operating items
Research & Development (Quarter)
132.10M347.96M135.83M132.00M393.36M125.13M114.79M332.35M120.51M143.07M405.18M152.92M164.57M482.87M202.02M
Selling, General & Administrative (Quarter)
437.78M636.06M149.07M157.66M475.00M156.19M88.58M308.03M99.89M202.88M444.32M134.02M143.12M452.22M165.53M
Other Operating Expenses (Quarter)
66.47M1.73M16.71M14.17M27.85M0.21M0.23M0.71M0.15M0.11M0.96M0.28M
Operating Expenses (Quarter)
698.42M1,130.90M286.63M293.30M975.06M298.04M217.54M668.24M220.61M346.19M850.20M287.09M307.80M936.05M367.83M
Operating Income (Quarter)
-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M-365.99M
EBIT (Quarter)
-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M-365.99M
Non-operating items
Non Operating Investment Income (Quarter)
443.75M443.75M-24.55M-54.68M-53.28M-7.56M-45.85M-63.88M15.23M48.38M42.29M-19.12M128.50M130.97M36.64M
Interest & Investment Income (Quarter)
0.06M0.20M1.98M5.67M17.90M16.71M14.30M62.97M72.13M69.77M203.75M0.47M2.58M136.93M36.92M
Other Non Operating Income (Quarter)
-1.08M-5.95M18.09M4.59M12.76M17.35M-3.61M-1.45M-7.88M-11.21M-5.69M-8.56M-2.13M
Non Operating Income (Quarter)
-2.20M2.84M-5.95M18.09M
Net income details
EBT (Quarter)
-225.24M-632.27M-349.79M-313.76M-1045.62M-326.09M-241.41M5,153.55M-19.64M-224.38M-478.54M-269.26M-159.04M-718.67M-294.56M
Tax Provisions (Quarter)
0.40M0.53M4.00M2.17M8.98M1.75M3.24M27.28M11.96M12.46M-25.57M4.65M7.00M34.98M-3.96M
Profit After Tax (Quarter)
-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-331.12M5,154.47M57.49M-279.92M169.38M-273.91M-166.04M-753.65M-290.61M
Income from Non-Controlling Interests (Quarter)
-17.16M-57.60M-21.98M-24.33M-79.19M-36.03M-26.79M-86.34M-37.81M-49.74M-138.85M-50.56M-52.52M-150.89M-100.77M
Income from Continuing Operations (Quarter)
-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-244.64M5,126.27M-31.60M-236.84M-452.97M-273.91M-166.04M-753.65M-290.61M
Income from Discontinued Operations (Quarter)
0.52M3.90M0.69M0.80M-0.86M
Consolidated Net Income (Quarter)
-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M-290.61M
Income towards Parent Company (Quarter)
-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M-290.61M
Net Income towards Common Stockholders (Quarter)
-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M-290.61M
Additional items
EPS (Basic) (Quarter)
-0.35-0.92-0.51-0.45-1.48-0.43-0.11-0.280.12-0.060.52-0.40
EPS (Diluted) (Quarter)
-0.35-0.92-0.51-0.45-1.48-0.43-0.11-0.270.11-0.060.52-0.40
Shares Outstanding (Quarter)
650.23M686.59M669.75M695.88M699.89M713.32M712.79M759.27M770.23M800.59M783.25M735.82M735.47M722.72M725.40M680.29M680.95M696.86M693.86M720.78M
Shares Outstanding (Diluted) (Quarter)
650.23M686.59M669.75M695.88M699.89M713.32M712.79M759.27M770.23M844.46M831.05M781.63M735.47M722.72M725.40M680.29M680.95M696.86M693.86M720.78M
EBITDA (Quarter)
-684.43M-1084.84M-282.31M-280.77M-941.15M-276.41M-213.89M5,127.45M-102.23M-341.71M-718.33M-284.92M-306.23M-930.31M-365.99M
Interest Expenses (Quarter)
13.33M5.57M20.65M11.86M11.32M19.39M11.68M9.55M9.30M27.60M11.56M81.40M115.00M113.20M701.22M0.18M0.07M1,596.93M6.57M
Tax Rate (Quarter)
-0.18-0.08-1.14-0.69-0.86-0.54-1.340.53-60.91-5.555.34-1.73-4.40-4.871.34